Post

New research · Internal Medicine
Annals of vascular surgery · 3h
Cohort studyAnnals of vascular surgery · 2026

Deep Vein Thrombosis in Hospitalized Patients With COVID-19: Incidence, Distribution, Predictors, and Clinical Outcomes in a Brazilian Tertiary Center.

Osmar Max Gonçalves Neves, Guilherme Neves Lima, Paula Santos Nunes … Adriano Antunes De Souza Araújo
Read paper
Internal MedicineCohort study

Prior deep vein thrombosis was the strongest predictor of deep vein thrombosis in hospitalized COVID-19 patients.

Deep Vein Thrombosis in Hospitalized Patients With COVID-19: Incidence, Distribution, Predictors, and Clinical Outcomes in a Brazilian Tertiary Center.

Osmar Max Gonçalves Neves … Adriano Antunes De Souza Araújo
Annals of vascular surgery · 2026
Purpose

To assess the incidence, anatomical distribution, and independent clinical predictors of deep vein thrombosis (deep vein thrombosis) among patients hospitalized with COVID-19 in a Brazilian tertiary-care center.

Methods

This retrospective cohort study included 5,831 hospital admissions (2020-2024) with complete deep vein thrombosis data.

n = 19 patients
Results

a history of deep vein thrombosis raises the odds of a new one far more than any other factor

AOR by subgroup · 95% CI
null = 1
Independent predictors of DVT included
18.30
obesity
3.21
smoking
2.59
oxygen requirement
4.86
More results

Deep vein thrombosis was infrequent but strongly associated with COVID-19 severity.

Most events were acute and predominantly involved the left lower extremity.

“
Conclusion · 1 of 2

Although uncommon, deep vein thrombosis in hospitalized COVID-19 patients was associated with substantial morbidity and mortality. A prior history of venous thrombosis was the strongest predictor, identifying a high-risk subgroup.

Conclusion · 2 of 2

The occurrence of clinically significant deep vein thrombosis despite routine pharmacological prophylaxis supports the need for risk-adapted diagnostic strategies, including targeted use of venous Doppler ultrasound.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
0.8%
an oversedation event needing naloxone reversal was rare
Randomized Trial
t = -4.35
intervention caregivers asked more questions than controls
Cohort Study
67.8%
one-year survival was far worse than the intermediate-risk group's, roughly one in three died
Review
50-100%
rheumatoid arthritis raises blood clot risk well above the general population
Cross-sectional
SIR 9.93
risk climbs sharply when relatives cluster and clotting starts young
Study
82.5%
guideline-recommended anticoagulation reached most hospitalized af patients after screening
Study
7.74
Average knowledge score rose from 5.24 to 7.74 after the education intervention
Cohort Study
34.4%
just over a third stayed safely anticoagulated, most were not